-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
DiaMedica Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q3 2024.
- DiaMedica Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$6.27M, a 40.3% decline year-over-year.
- DiaMedica Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$21.7M, a 20.8% decline year-over-year.
- DiaMedica Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$19.4M, a 41.7% decline from 2022.
- DiaMedica Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$13.7M, a 0.62% decline from 2021.
- DiaMedica Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$13.6M, a 10.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)